Type 2 & other diabetes

Economic evaluation of NT-proBNP testing plus standard clinical assessment versus standard clinical assessment alone for the prevention of heart failure in older adults with type 2 diabetes

BMJ Open Diabetes Res CarePublished Cost-effectiveness analysis

Authors' conclusion

Annual NT-proBNP testing in older adults with type 2 diabetes is cost-effective for early HF detection in a Medicare setting

Study context

Population
Adults aged ≥65 years with T2D, with or without other heart failure (HF) risk factors; model inputs from published literature and Medicare data
Comparison
NT-proBNP testing plus standard clinical assessment vs standard clinical assessment alone
Outcome
Direct medical costs, life-years (LYs) and quality-adjusted life-years (QALYs)
Follow-up
Lifetime horizon
Methodological detailsMarkov model with embedded decision tree, five-state Markov model, lifetime horizon, Medicare perspective, sensitivity and scenario analyses
  • Markov model with embedded decision tree
  • Five-state Markov model
  • Lifetime horizon
  • Medicare perspective
  • Sensitivity and scenario analyses

Main finding

As reported in the abstract

Cost-effectiveness: QALYs over a lifetime horizon (Medicare perspective)
NT-proBNP was cost-effective: incremental cost per QALY gained
US$40 883

Further findings

Survival (LYs) · lifetime

Lifetime costs

OutcomeNT-proBNP testingStandard clinical assessment
Lifetime HF hospitalizations0.430.43
LY-adjusted HF hospitalizations · lifetime0.290.43
  • Lifetime costs: reflecting longer survival and greater use of cardioprotective treatments

Sensitivity analyses

Results robust; most sensitive to diabetes management costs, mortality among high-risk individuals and cardioprotective drug effectiveness

Original publication

Economic evaluation of NT-proBNP testing plus standard clinical assessment versus standard clinical assessment alone for the prevention of heart failure in older adults with type 2 diabetes. BMJ Open Diabetes Res Care. Published 28 September 2026. doi:10.1136/bmjdrc-2026-006304

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.